Connect with us

Cannabis News

Nebraska Senator Files Formal Challenge To Restrictive Medical Marijuana Rules Signed By Governor

Published

on

“The Commission is not free to take own definition of cannons than the more restrictive definition in the statute.”

Zach Wendling, by the Nebraska examiner

A state legislature has a formally challenging regulations of the Nebraska Medical Cannabis Committee.

Omaha, Omaha, Omaha, directs a director of Omaha Sainter’s Sainter. Emergency rules spent by the Commission This summer. Commissioners expect to become a final regulations and from 3:00 p.m. They have programmed public hearing in the Nebraska State Office building in Lincoln, October 15 to receive feedback.

The regulations between Cavanaugh’s complaints:

  • Limit the availability of medical cannabis products to be sold to the close list of licensed while the law has no limits.
  • Allow state health practitioners to recommend medical cannabis, while voters allowed doctors to do so.
  • Banning the burning or combination of medical cannabis while it allows any device to evaporate or inhaled by laws specifically.

“Without the benefit of a public audition or government, the Commission and the governor do not have Nebanaugh in Blair (R) Blair (written by the United States of the Executive Committee of Legi.

From December, Nebraskans could legally have 5 ounces of Medical Cannabis while the health practitioner recommends. But without a licensed establishment, it is still unable to buy it in State.

The voter gave the commission until July 1 to issue regulations and October 1 to issue licenses, a The period that will be lost at least for a week following two curators following resignation.

Complaint is the first step

A State Senator can form a formally challenging state agency regulations and the process of written response will begin to find out the rules of legislation and why they are required. In November, 71 percent of Nebraska voters voted for legalizing medical cannabis and voted by 67% of the voters to create a new regulation committee.

Hansen will refer to Cavanuagh complaint to Bellevue (r) Sen. Rick Holdcroft (r) President of the Committee of Relatives, which will be thought of the Cannabis Committee on Medicine Committee. The Commission would have 60 days to respond to respond.

Holdcroft said he still didn’t see Cavanaugh on Thursday yet. He is the Vice-President of the General Committee for Cavanaugh.

Hansen, only a “mediator” in the complaint process, says Cavanaugh believes that the complaint is “legit”.

“It’s not just the people voted, exactly the dates, but I think opening a situation is delaying a lawsuit,” Hansen said. “I think the complaint to look legitimate and maybe if we should look at things as a legislature.”

Cavanaugh proposed to leave himself grievance Listen to October 31 Legislative resolution 226Therefore, Cavanaugh Holdcroft and Hansen’s support submitted with the help of the provisional studies to see how the cannabis laws are carried out by the voters.

Holdcroft said that the 2024 votes measure has to invite the commissioners and nebraska.

Nebraska’s judges have legal discretion if they violate the regulatory constitutions, exceeding the Statute Authority of the Agency or without accepting statutory procedures. “

The legislators reaffirmed this judiciary in the spring and, starting in May, in order to be presented in any court’s court, no more in the courts of Lancaster County district.

Commission regulations

Included in the proposed regulations, national doctors could be a condition that could be “recommended health care practitioners”. These Nebraska practitioners could only be made to Nebraska licensed. The participating doctors should also do an annual education related to the Medical Canavy.

Cavanaugh said Education can make sense, that is the legislature policy option. He highlighted the legislature that this spring had the opportunity to create a more restrictive medical cannabis program but ultimately, no.

The legislature exceeded legal protections for the doctors recommended by the doctor who recommends doctors.

“The Commission is not free to take the own definition of cannabis that is more restrictive than the definition in the statute,” Cavanaugh wrote.

The regulation would also do Limit nebraska into certain types of cannabisIncluding raw flowers, lands and delta-9 tetrahydrocannabinol (THC), the “high” part of the plant is “high”. Patients would be limited to 5 grams of 5 grams per day. Five ounces is equivalent to 141 grams.

Cavanaugh would take seven years for a patient to get a delta-9 thc 5 ounce, but voters have not established thc restrictions.

According to the regulations, each of the four crops can have 1,250 flower plants at the same time, with a maximum of four product manufacturers and 12 states of dispensers.

In addition to mentioning the comments written on October 15, they can be sent on October 15: October 15 Nebraska Medical Committee, PO Box 95046, Lincoln, NE 68509-5046; by fax via 402-471-2814 or email (Protected by email).

Medicinal Vs. Leisure

The government approved Emergency rules with Jim Pillen (R), along with the stipulation of a plant cap, will eventually decide to end a set of regulations in the end. He said his name will ensure that the Nebraska cannabis program is maintained by medicinal plants.

Hansen legal bill 677 LEG This spring, with the help of a doctor’s cannabis advocate. He wanted to help the Commission in law already putting many regulations. In many public forums directed by Hansen, Cavanaugh and Holdcroft, voters said they would help the recreationary marijuana in the State leaders on the way to the medical cannabis.

“The Commission is a marijuana against the fear of the governor and Senators, I can say that the safest way of ensuring voters to ensure that the next step is that the medical cannabis has clearly expressed itself,” said Tuesday.

This Monday has searched and received two resignations, columns, and then federal public corruption charges will be punished last week against the Executive Director of the Nebraska Likor Control Committee. Guilty is not guilty.

The three-liquor commissioner also serves to the Cannabis Medical Committee. No commissioners involve federal.

Holdcroft said he was “completely surprised” for the alleged behavior of the former director. However, he said the Likor Control Committee worked on Míah Chaffee’s Mid September, Holdcroft and a Research Assistant, with Chaffee issues related to liquor and cannons.

“It’s a family man. It has high moral rules. I have a great deal of moral rules,” Holdcroft said Chaffee said HoldCress. “To replace both of his leadership and governor’s appointment for some quality curators, I think we should be fine.”

‘Legislature must be played’

The Cannabis Doctors Committee will return next Tuesday when the first laboratory licenses are expected to vote. Still, getting the seed from sale is not going to happen until the center of 2026.

Some legislators voted against Hansen’s LB 677 in May, they wanted to wait for legal challenges to address the challenges that follow that date and threatening. Among the threatening legal action is the Office of the Nebraska Lawyers. Cavanaugh said that regulatory process has also increased legal risks.

Other senators wanted to give the Commission to action, Cavanaugh said that the “Moot argument”.

He said Cavanaugh: “Legislators to ensure the will of voters will be seen.”

This story first published the Nebraska examiner.

Photo courtesy Carlos Gracia.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Continue Reading

Cannabis News

Fluent to sell New York license and operations

Published

on

By











Fluent has entered into a definitive agreement to sell Etain, LLC, the Company’s New York-based operating entity. The purchase agreement was signed on July 22, 2026. The transaction provides for the sale of Etain’s Registered Entity license, certain of the Company’s New York operating assets and related New York leases for cash, subject to customary purchase price adjustments.

The Company believes the Transaction advances its strategic objectives and expects the Transaction to comply with applicable regulatory requirements in connection with the Company’s previously announced plan of arrangement for Vireo Growth Inc. (the “Deal”) while providing for an orderly transition of the New York operations to an experienced operator committed to serving patients and consumers.

Completion of the free transaction is subject to closing conditions, including, among other customary conditions, approval of the change in ownership by the New York State Cannabis Control Board and the completion of all conditions to the completion of the Agreement.

For more information:
FLUENT Corp
getfluent.com/










Continue Reading

Cannabis News

Marijuana Has ‘Horrific Health Risks’ And No Medical Value, Former Trump Attorney General Claims

Published

on

By

A former US attorney general who served in President Donald Trump’s first term says marijuana poses “tremendous health risks,” has no medical value and should not be rescheduled under federal law.

“Marijuana redistricting would create a false impression that it is safe, reduce penalties for illegally selling the drug, and provide a large tax windfall to those who legally supply it,” William Barr wrote in a Wednesday op-ed for The Washington Post, Kevin Sabet, CEO of the prohibitionist organization Smart Approaches to Marijuana. “That would be a disaster.”

The opinion comes as the Trump administration moves forward with cannabis reregulation.

According to an order issued in April by US Attorney General Todd Blanche, Marijuana products regulated by a state medical cannabis license were immediately changed from Schedule I As did marijuana products approved by the Food and Drug Administration (FDA) under Schedule III of the Controlled Substances Act (CSA).

an administrator The hearing is looking at the broader rescheduling of marijuanawith The Drug Enforcement Administration (DEA) has been tasked with advocating for cannabis reform highlighting the testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids. It included appearances by a Food and Drug Administration (FDA) scientist and a doctor from New Hampshire. Medical marijuana provides relief to pain patients and can serve as an alternative to opioids.

But Sabet and Barr, who served as Trump’s attorney general from 2019-2020, argued that “the evidence presented at the hearing did not support the rescheduling of marijuana” and instead “confirmed what decades of data have shown: raw marijuana has no scientifically established medical value and is highly susceptible to abuse.”

After the parties to the hearing have filed termination rights, the DEA administrative law judge overseeing the proceedings will make a recommendation regarding rescheduling, and the agency administrator will make a final decision.

DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling supporters that they do not meet the definition of “interested person” to participate because they have not been “affected or prejudiced by any rule or proposed rule that may be issued.”

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The former attorney general’s new opinion says “the stakes couldn’t be higher”, arguing that “marijuana today is more dangerous than ever” and that it is “addictive”, throwing out a list of alleged harm to mental and physical health.

“These unhealthy effects are a predictable result of a powerful and addictive drug being normalized, commercialized and marketed as a medicine,” Barr and Sabet say. “It would be one thing if marijuana had medical value. But there is no credible evidence that marijuana is an effective treatment for any medical condition, despite the millions of dollars spent trying to prove otherwise.”

The Department of Health and Human Services (HHS) published a 252 analysis in 2023 that concluded that marijuana had accepted medical value and should be rescheduled.

The new opposition piece also says that “rescheduling would unlock enormous revenue for the corporate marijuana industry by bringing it into a category that has not been covered by a longstanding reduction in federal drug tax deductions,” referring to a law known as 280E, which repeals Sections I and II.

“This, in turn, would allow the industry to spend even more on advertising and marketing to young people,” Barr and Sabet. he wroteArguing that “those who would lose this dragon in society are laying the foundations for another Big Tobacco”.

The Sabet organization, SAM, is one of several parties Challenging the Marijuana Redistricting Process which have been upheld by a federal Court of Appeals. those separate parts State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

SAM’s lawsuit was signed by attorneys at Torridon Law PLLC, where Barr is a partner.

The team announced in January that it was Hiring Barr’s firm to fight cannabis rescheduling After Trump signed an executive order directing officials to quickly complete the process.

During the first Trump administration, Barr was accused by a Justice Department official Directing improper anti-company investigations into multiple cannabis company mergers– Accounting for almost a third of the division’s cases in 2019.

Several Democratic members of Congress introduced a resolution calling for an investigation into Barr’s possible impeachment, saying “abused the power of his office” to improperly investigate marijuana businesses while engaging in other allegedly illegal conduct.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

How much red light does cannabis really need?

Published

on

By

When growers pull out two LED fixtures side by side, the first number they usually discuss is percent red. This is an easy specification to fix. They are efficient at producing red photons and incredibly efficient at photosynthesis, and cannabis eats away at the flower. So more red must be better, right?

Not so simple. Red is an input to a spectrum, and the spectrum is an input to a room. There is no single spectrum that wins everywhere. An indoor room pushes hard, a greenhouse that soaks up sunlight, a temperamental cultivar, and aggressive yields call for something different. Knowing what each light strip actually does allows you to choose a tool that fits your grow instead of one that just has a big number on the sales page.

© JumpLights

Blue: structure
Blue (approximately 400-500 nm) gives shape to the plant. It maintains dense growth, strong stems, tight internodes and allows it to develop as desired. It also encourages stomatal opening, so the plant manages water and gas exchange better. Get blue and you’ve built a plant that can carry heavy flowers with no problem.

Green: access
Green was eliminated as the wavelength is “reflected” by plants. It turns out that it does a real job. Blue and red are absorbed above; the green goes deep into the fat and reaches the leaves that are never touched by the above photons. In a compact room, it’s the difference between plants photosynthesising from the top down and those that work only from the top. Green won’t replace your red or blue, but it does carry usable light where they can’t reach.

Red: engine
Red is the horse of the flower. It absorbs as efficiently as anything in the spectrum, and is responsible for most of the biomass you’re after. Redder generally means faster flower development, more weight and better efficiency per watt.

But red has a ceiling, and it’s tied to what you run. Push PPFD upwards with a heavy red spectrum and some cultivars begin to whiten at the top: the flower should be dense with pale, washed tips. Genetics, intensity, barrel temperature and your general environment all feed into it. If you’re using aggressive light levels, a lower red spectrum will buy you room before that becomes a problem, leaving you almost no photosynthetic punch to get it.

Far Red: More than Emerson
Far-red (700-750 nm) appears in more devices every year. It contributes little to photosynthesis on its own, but it moves plant morphology and works with red through the Emerson Enhancement Effect. Used properly, it helps to deepen the light, encourage uniformity of the canopy and encourage the response of the bloom. The key word is small. A touch of far red rounds out a spectrum; he’s not there to make a show.

Matching the red percentage with the room
Cannabis addresses the entire spectrum, not a line on a spec sheet. Reds cause flowers, but blues, greens and crimsons give the plant something it needs. Where you land in red refers to how you grow.

A lower red spectrum (30-40%) captures more blue and green, gives you better morphology, reduces the risk of photobleaching, and holds up when you’re running extreme PPFD. Moderate spectrum (40-55%) is the sweet spot in commercial greenhouses: strong photosynthetic efficiency, strong flowering, balanced growth. A high-red spectrum (70%+) makes the most sense in a greenhouse, where the sun is already giving you lots of blue and green and your supplemental light can cast effective red to fill the gap.

Where does the ETS MAX series fit in?
This is the thinking behind the JumpLights ETS MAX series. Instead of forcing a spectrum into each room, it rarely comes up because a greenhouse and a high PPFD indoor flower room are not the same problem.

  • ETS MAX 4C41% red: for indoor rooms operating at very high intensity, where photobleaching is a real risk. The wider, red bottom balance allows you to push the tops without overcooking them
  • ETS MAX 4A48% red: balanced internal spectrum that maintains high output while controlling bleaching.
  • ETS MAX 5B57% Red: A high-performance indoor option. Moderate red, marked with efficiency and flower at the same time, up to 3,450 μmol/s, with efficiency that holds the spectrum.
  • ETS MAX 7A76% red: built for the greenhouse. The sun already supplies blue and green, so this leans heavily on the complementary red, up to 3,900 μmol/s in the infrastructure most greenhouses already have in place.

Bottom line
Choosing an activity is not a competition for the highest red number. The winning spectrum is the one that matches your environment, your intensity, your genetics, and what you’re trying to produce. Combine spectrum, intensity, environmental control, light distribution and genetics, and you’ve got a lighting strategy. Keep a spec isolated and all you’ve got is a bright room.

The ETS MAX line was created around this idea: choose the spectrum of the room you actually have, indoor or greenhouse, and let the device work with your grow rather than against it.

For more information:
JumpLights
www.jumplights.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media